Skip to main content

Production of Recombinant Blood Factors in Transgenic Plants

  • Chapter
Chemicals via Higher Plant Bioengineering

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 464))

Abstract

The production of recombinant proteins for therapeutic use in transgenic plants has become an alternative to the isolation of these molecules from natural or other recombinant sources. Plant bioreactors offer the possibility of an inexpensive large scale production of high volumes of recombinant proteins with increased safety concerning contaminations with human pathogens. Several laboratories are involved in the commercial production of the first recombinant products, such as antibodies or recombinant human hemoglobin, from transgenic plants.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Dalsgaard, K., Uttenthal, A., Jones, T.D., Zu, F., Merryweather, A., Hamilton, W.D.O., Langeveld, J.P.M., Boshuizen, R.S., Kamstrup, S., Lomonossoff, G.P., Porta, C., Vela, C., Casal, J.I., Meloen, R.H. and Rodg-ers, P.B. Plant-derived vaccine protects target animals against a viral disease. Nature Biotechnology 1997, 15,248–252.

    Article  PubMed  CAS  Google Scholar 

  • Dieryck, W., Pagnier, J., Poyart, C., Marden, M.C., Gruber, V., Bournat, P., Baudino, S. and Merot, B. Human haemoglobin from transgenic tobacco. Nature (London) 1997, 386, 29–30.

    Article  CAS  Google Scholar 

  • Dodet, B. Production de protéines recombinantes: quel system choisir? Biofutur 1990, 91, 20–29.

    Google Scholar 

  • Gomord, V., Sailer J-P. et Faye L. Plante et médicament, un nouveau départ. Biofutur 1996, 154, 26–30.

    Article  Google Scholar 

  • Gomord, V. and Faye, L. Signals and mechanisms involved in intracellular transport of secreting proteins in plants. Plant Physiol. Biochem. 1996, 34, 165–181.

    CAS  Google Scholar 

  • Haq, T.A., Mason, H.S., Clements, J.C. and Arntzen, C.J. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 1995 268, 714–716.

    Article  PubMed  CAS  Google Scholar 

  • Hennighausen, L., Ruiz, L. and Wall, R. Transgenic animals — production of foreign proteins in milk. Curr. Opin. Biotechnol. 1990, 1, 74–78.

    Article  PubMed  CAS  Google Scholar 

  • Ma, J.K.C., Hiatt, A., Hein, M., Vine, N.D., Wang, F., Stabila, P., Van Dolleweerd, C., Mostov, K. and Lehner, T. Generation and assembly of secretory antibodies in plants. Science 1995, 268, 116–719.

    Article  Google Scholar 

  • Mason, H.S., Ball, J.M., Shi, J.J., Jiang, X., Estes, M.K. and Arntzen, C.J. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl Acad. Sci. USA 1996, 93, 5335–5340.

    Article  PubMed  CAS  Google Scholar 

  • McGravey, P.B., Hammond, J., Dienelt, M.M., Hooper, D.C., Fu, Z.F., Dietzschold, B., Kprowski, H. and Michaels, F.H. Expression of the rabies virus glycoprotein in transgenic tomatoes. Bio/Technology 1995, 13, 1484–1487.

    Article  Google Scholar 

  • McLain L., Durrani, Z., Wisniewski, L.A., Porta, C., Lomonossof, G.P. and Dimmock, N.J. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp 41 expressed on the surface of a plant virus. Vaccine 1996 14, 799–809.

    Article  PubMed  CAS  Google Scholar 

  • Moffat, A.S. Exploring transgenic plants as a new vaccine source. Science 1995, 268, 658–660.

    Article  PubMed  CAS  Google Scholar 

  • Porta, G., Spall, V, Loveland, J., Johnson, J., Barker, P. and Lomonossoff, G. Development of cowpea mosaic virus as a high-yield system for the presentation of foreign peptides. Virology 1994, 202, 949–955.

    Article  PubMed  CAS  Google Scholar 

  • Sijmons, P.C., Dekker, B.M.M., Schrammeijer, B., Verwoerd, T.C., Van den Elzen, P.J.M. and Hoekema, A. Production of correctly processed human serum albumin in transgenic plants. Bio/Technology 1990, 8, 217–221.

    Article  PubMed  CAS  Google Scholar 

  • Thanavala, Y., Yang, Y.F., Lyons, P., Mason, H.S. and Arntzen C. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Nati Acad. Sei. USA 1995, 92, 3358–3361.

    Article  CAS  Google Scholar 

  • Verbert, A. La glycosylation des protéines recombinantes. Biofutur 1993, 125, 40–44.

    Google Scholar 

  • Wandelt, C.I, Rafiqul M., Khan, L, Craig, S., Schroeder, H.E., Spencer D. and Higgins, T.J.V. Vicilin with car-boxy-terminal KDEL is retained in the endoplasmic reticulum to high levels in leaves of transgenic plants. Plant J. 1992, 181–192.

    Google Scholar 

  • Whitelam, G.C. and Cockburn, W. Antibody expression in transgenic plants.Trends Plant Sci. 1996, 8, 268–272.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Theisen, M. (1999). Production of Recombinant Blood Factors in Transgenic Plants. In: Shahidi, F., Kolodziejczyk, P., Whitaker, J.R., Munguia, A.L., Fuller, G. (eds) Chemicals via Higher Plant Bioengineering. Advances in Experimental Medicine and Biology, vol 464. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4729-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4729-7_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7143-4

  • Online ISBN: 978-1-4615-4729-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics